Atricure Inc. buy Needham & Company LLC
Start price
13.02.25
/
50%
€29.29
Target price
13.02.26
€49.06
Performance (%)
8.57%
Price
15.01.26
€31.80
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL shows slight gains of 8.57%. This prediction currently runs until 13.02.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -14.917% | -14.917% |
| iShares Core DAX® | 0.336% | 4.366% |
| iShares Nasdaq 100 | 0.541% | 3.170% |
| iShares Nikkei 225® | 4.048% | 6.727% |
| iShares S&P 500 | 0.795% | 3.281% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat